Shanghai Shyndec Pharmaceutical Co., Ltd. (600420.SS) SHH
9.04
-0.23(-2.48%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
Shanghai Shyndec Pharmaceutical Co., Ltd.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
11472
First IPO Date
June 16, 2004
Key Executives
| Name | Title | Pay | Year Born |
| Xiangchen Wang | Chief Financial Officer | 0 | 1972 |
| Lei Gao | Accounting Supervisor | 0 | N/A |
| Zhongxi Zhang | Vice President & Board Secretary | 0 | 1976 |
| Yong Liu | President & Director | 0 | 1969 |
Description
Shanghai Shyndec Pharmaceutical Co., Ltd. manufactures drug preparation products in China and internationally. It focuses on anti-infection, cardiovascular and cerebrovascular, anti-tumor, metabolism, and endocrine areas. The company was founded in 1996 and is based in Shanghai, China.
